Evidence map›Paper›PMID 8878609›Full record

ArticleAntimicrobial agents and chemotherapy1996

Use of Mono Mac 6 human monocytic cell line and J774 murine macrophage cell line in parallel antimycobacterial drug studies.

E L Wright, D C Quenelle, W J Suling, W W Barrow

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

E L WrightMycobacteriology Research Unit, Southern Research Institute, Birmingham, Alabama 35205, USA.
D C Quenelle
W J Suling
W W Barrow

Funding

PROCESSING OF MYCOBACTERIAL GLYCOPEPTIDOLIPID ANTIGENSR01AI021946 · NIAID · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI BARROW, WILLIAM · 1985 to 1996
–
TREATMENT OF TB WITH MICROENCAPSULATED DRUGSR01AI038185 · NIAID · SOUTHERN RESEARCH INSTITUTE · PI BARROW, WILLIAM · 1995 to 1998
–
NIAID NIH HHS AI 21946NIAID NIH HHS AI 38185
6 · The paper itself

Abstract

The Mono Mac 6 (MM6) human monocytic cell line was evaluated with the established J774 murine macrophage cell line to ascertain its effectiveness in determining the intracellular activities of antimycobacterial drugs. Cells were infected with Mycobacterium tuberculosis H37Ra and treated with drug concentrations corresponding to the MICs, as well as to threefold higher than and threefold less than the MICs. Changes in CFU were compared after 7 days to determine significant differences between treated and nontreated groups. The results suggest that MM6 will make a useful model for testing the intracellular activities of antituberculosis drugs.

Indexed as

AnimalsAntitubercular AgentsCell LineCell SurvivalColony Count, MicrobialHumansMacrophagesMiceMicrobial Sensitivity TestsMonocytesMycobacterium tuberculosisAntitubercular Agents

Identifiers

PMID8878609
PMCPMC163501

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.